DRUG-INDUCED MANIA

被引:95
作者
PEET, M
PETERS, S
机构
[1] The University Department of Psychiatry, Northern General Hospital, Sheffield, S5 7AU, Herries Road
关键词
D O I
10.2165/00002018-199512020-00007
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Mania can occur by chance association during drug treatment, particularly in patients predisposed to mood disorder. Single case reports are unreliable, and evidence must be sought from large series of treated patients, particularly those with a matched control group. Drugs with a definite propensity to cause manic symptoms include levodopa, corticosteroids and anabolic-androgenic steroids. Antidepressants of the tricyclic and monoamine oxidase inhibitor classes can induce mania in patients with pre-existing bipolar affective disorder. Drugs which are probably capable of inducing mania, but for which the evidence is less scientifically secure, include other dopaminergic anti-Parkinsonian drugs, thyroxine, iproniazid and isoniazid, sympathomimetic drugs, chloroquine, baclofen, alprazolam, captopril, amphetamine and phencyclidine, Other drugs may induce mania rarely and idiosyncratically. Management involves discontinuation or dosage reduction of the suspected drug, if this is medically possible, and treatment of manic symptoms with antipsychotic drugs or lithium.
引用
收藏
页码:146 / 153
页数:8
相关论文
共 93 条
[1]  
Diagnostic and statistical manual of mental disorders, (1994)
[2]  
Leff J.P., Fischer M., Bertelsen A., A cross-national epidemiological study of mania, Br J Psychiatry, 129, (1976)
[3]  
Sultzer D.L., Cummings J.L., Drug-induced mania-causative agents, clinical and characteristics and management, Med Toxicol Adverse Drug React, 4, (1989)
[4]  
Krauthammer C., Klerman G.L., Secondary mania, Arch Gen Psychiatry, 35, (1978)
[5]  
Cotzias G.C., van Woert M.H., Schiffer L.M., Aromatic amino acids and modification of Parkinsonism, N Engl J Med, 276, (1967)
[6]  
Goodwin F.K., Psychiatric side-effects of levodopa in man, JAMA, 218, (1971)
[7]  
Presthus J., Holen R., Appraisal of long-term levodopa treatment of parkinsonism with special reference to therapy-limiting factors, Acta Neurol Scand, 50, (1974)
[8]  
Lin J-Y, Zeigler D., Psychiatric symptoms with initiation of carbidopa-levodopa treatment, Neurology, 26, pp. 679-700, (1976)
[9]  
Harsch H.H., Miller M., Young L.D., Induction of mania by 1-dopa in a nonbipolar patient, J Clin Psychopharmacol, 5, (1985)
[10]  
Mindham R.H.S., Psychiatric symptoms in Parkinsonism, J Neurol Neurosurg Psychiatry, 33, (1970)